M. Hatton

6.8k citations

96 papers · 3.3k indexed · 2 hit papers · h-index 25

Impact in

Oncology top 1%
- Lung Cancer Research Studies
Pulmonary and Respiratory Medicine top 1%
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Brain Metastases and Treatment

Papers in ⓘ

Radiation 30
- Advanced Radiotherapy Techniques 23
Pulmonary and Respiratory Medicine 64
- Lung Cancer Diagnosis and Treatment 39
- Lung Cancer Treatments and Mutations 23
- Brain Metastases and Treatment 11
- Radiation Therapy and Dosimetry 8

Co-authors: Corinne Faivre‐Finn (24 shared papers)Suresh Senan (13 shared papers)Ben J. Slotman (10 shared papers)Elaine M. Rankin (6 shared papers)M. Snee (6 shared papers)Laurence Collette (5 shared papers)G. Kramer (6 shared papers)Pieter E. Postmus (4 shared papers)
Journals: Clinical Oncology (16 papers)Radiotherapy and Oncology (11 papers)Lung Cancer (9 papers)International Journal of Radiation Oncology*Biology*Physics (8 papers)Journal of Thoracic Oncology (7 papers)
Partner nations: United Kingdom Netherlands United States

In The Last Decade

M. Hatton

89 papers receiving 3.3k citations

Hit Papers

align trajectories log scale

Use of thoracic radiotherapy for extensive stage small-cell lung cancer: a phase 3 randomised controlled trial 2014 · 384 citations

Peers

Countries citing papers authored by M. Hatton

Since Specialization

Citations

This map shows the geographic impact of M. Hatton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Hatton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Hatton more than expected).

Fields of papers citing papers by M. Hatton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Hatton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Hatton. The network helps show where M. Hatton may publish in the future.

Co-authors

The 25 scholars most cited alongside M. Hatton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with M. Hatton Line = papers co-authored together M. Hatton links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 96 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Prophylactic Cranial Irradiation in Extensive Small-Cell Lung Cancer New England Journal of Medicine ·Ben J. Slotman, Corinne Faivre‐Finn, G. Kramer, Elaine M. Rankin, M. Snee, M. Hatton, Pieter E. Postmus, Laurence Collette, E. Musat, Suresh Senan Hit paper breakdown →	2007	711
2	Use of thoracic radiotherapy for extensive stage small-cell lung cancer: a phase 3 randomised controlled trial The Lancet ·Ben J. Slotman, Harm van Tinteren, J. Praag, J. Knegjens, Sherif Y. El Sharouni, M. Hatton, Astrid Keijser, Corinne Faivre‐Finn, Suresh Senan Hit paper breakdown →	2014	384
3	Preoperative chemotherapy in patients with resectable non-small cell lung cancer: results of the MRC LU22/NVALT 2/EORTC 08012 multicentre randomised trial and update of systematic review The Lancet ·David Gilligan, M. Nicolson, Ian Smith, Harry J.M. Groen, Otilia Dalesio, Peter Goldstraw, M. Hatton, Penelope Hopwood, Christian Manegold, Franz M.N.H. Schramel, Hans J.M. Smit, Jan P. van Meerbeeck, Matthew Nankivell, Mahesh Parmar, Cheryl Pugh, Richard Stephens	2007	228
4	Prophylactic Cranial Irradiation in Extensive Disease Small-Cell Lung Cancer: Short-Term Health-Related Quality of Life and Patient Reported Symptoms—Results of an International Phase III Randomized Controlled Trial by the EORTC Radiation Oncology and Lung Cancer Groups Journal of Clinical Oncology ·Ben J. Slotman, Murielle Mauer, Andrew Bottomley, Corinne Faivre‐Finn, G. Kramer, Elaine M. Rankin, M. Snee, M. Hatton, Pieter E. Postmus, Laurence Collette, Suresh Senan	2008	164
5	Stereotactic ablative body radiotherapy in patients with oligometastatic cancers: a prospective, registry-based, single-arm, observational, evaluation study The Lancet Oncology ·Anastasia Chalkidou, Thomas Macmillan, Mariusz Grzeda, Janet L. Peacock, Jennifer Summers, Saskia Eddy, Bola Coker, Hannah Patrick, Helen Powell, Lee Berry, G. Webster, Peter Ostler, P. Dickinson, M. Hatton, Ann Henry, Stephen Keevil, M. Hawkins, N.J. Slevin, Nicholas van As	2020	138
6	First-line erlotinib in patients with advanced non-small-cell lung cancer unsuitable for chemotherapy (TOPICAL): a double-blind, placebo-controlled, phase 3 trial The Lancet Oncology ·Siow Ming Lee, Iftekhar Khan, Sunil Upadhyay, C. Lewanski, Stephen Falk, G. Skailes, Ernie Marshall, Penella J. Woll, M. Hatton, Rohit Lal, Richard C. Jones, Elizabeth Toy, David Chao, Gary Middleton, Sue Bulley, Yenting Ngai, Robin Rudd, Allan Hackshaw, Chris Boshoff	2012	133
7	Clinical neurological outcome and quality of life among patients with limited small-cell cancer treated with two different doses of prophylactic cranial irradiation in the intergroup phase III trial (PCI99-01, EORTC 22003-08004, RTOG 0212 and IFCT 99-01) Annals of Oncology ·C. Le Péchoux, A. Laplanche, Corinne Faivre‐Finn, Tudor–Eliade Ciuleanu, Rinus Wanders, D. Lerouge, Ronald B. Keus, M. Hatton, G.M. Videtic, Suresh Senan, Aaron H. Wolfson, Robert J. Jones, R. Arriagada, Élisabeth Quoix, Ariane Dunant	2010	130
8	Gemcitabine Plus Carboplatin Versus Mitomycin, Ifosfamide, and Cisplatin in Patients With Stage IIIB or IV Non-Small-Cell Lung Cancer: A Phase III Randomized Study of the London Lung Cancer Group Journal of Clinical Oncology ·R.M. Rudd, N.H. Gower, Stephen Spiro, Tim Eisen, Peter Harper, J.A.H. Littler, M. Hatton, Peter Johnson, William McChesney Martin, Elaine M. Rankin, L. E. James, W. Gregory, W. Qian, Siow Ming Lee	2004	121
9	Feasibility of Image Registration and Intensity-Modulated Radiotherapy Planning With Hyperpolarized Helium-3 Magnetic Resonance Imaging for Non–Small-Cell Lung Cancer International Journal of Radiation OncologyBiologyPhysics ·Rob H. Ireland, C. Bragg, M. McJury, Neil Woodhouse, Stan Fichele, Edwin J.R. van Beek, Jim M. Wild, M. Hatton	2007	90
10	Comparison of ³He and ¹²⁹Xe MRI for evaluation of lung microstructure and ventilation at 1.5T Journal of Magnetic Resonance Imaging ·Neil J. Stewart, Ho‐Fung Chan, Paul Hughes, Felix Horn, Graham Norquay, Madhwesha Rao, Denise P. Yates, Rob H. Ireland, M. Hatton, Bilal Tahir, Paul J. Ford, Andrew J. Swift, Rod Lawson, Helen Marshall, Guilhem Collier, Jim M. Wild	2018	66
11	The prevalence of menopausal symptoms in patients treated for breast cancer Clinical Oncology ·Peter Canney, M. Hatton	1994	65
12	Which patients with ES-SCLC are most likely to benefit from more aggressive radiotherapy: A secondary analysis of the Phase III CREST trial Lung Cancer ·Ben J. Slotman, Corinne Faivre‐Finn, Harm van Tinteren, Astrid Keijser, J. Praag, J. Knegjens, M. Hatton, Iris van Dam, A. Van der Leest, Bart Reymen, Jos A. Stigt, Kate Haslett, Devashish Tripathi, Egbert F. Smit, Suresh Senan	2017	60
13	Accelerated hypo-fractionated radiotherapy for non small cell lung cancer: Results from 4 UK centres Radiotherapy and Oncology ·Omar Din, Susan Harden, Emma Hudson, N. Mohammed, L. Pemberton, J.F. Lester, Debashis Biswas, L. Magee, Adnan Tufail, Ross Carruthers, G. Sheikh, David Gilligan, M. Hatton	2013	57
14	Functional image-based radiotherapy planning for non-small cell lung cancer: A simulation study Radiotherapy and Oncology ·Emma Bates, C. Bragg, Jim M. Wild, M. Hatton, Rob H. Ireland	2009	51
15	Functional Image-guided Radiotherapy Planning for Normal Lung Avoidance Clinical Oncology ·Rob H. Ireland, Bilal Tahir, Jim M. Wild, C.E. Lee, M. Hatton	2016	50
16	Escalation and Intensification of Radiotherapy for Stage III Non-small Cell Lung Cancer: Opportunities for Treatment Improvement Clinical Oncology ·John D. Fenwick, Alan E. Nahum, Zafar Malik, Chinnamani Eswar, M. Hatton, V. Laurence, J.F. Lester, David Landau	2009	43
17	Association of Chemoradiotherapy With Outcomes Among Patients With Stage I to II vs Stage III Small Cell Lung Cancer JAMA Oncology ·Ahmed Salem, Hitesh Mistry, M. Hatton, Imogen Locke, I. Monnet, Fiona Blackhall, Corinne Faivre‐Finn	2018	38
18	Reduced Fractionation in Lung Cancer Patients Treated with Curative-intent Radiotherapy during the COVID-19 Pandemic Clinical Oncology ·Corinne Faivre‐Finn, John D. Fenwick, K. Franks, Stephen Harrow, M. Hatton, Crispin T. Hiley, J. McAleese, Fiona McDonald, J. O’Hare, C. Peedell, Thomas Pope, Ceri Powell, R. Rulach, Elizabeth Toy	2020	36
19	Prophylactic Irradiation of Tracts in Patients With Malignant Pleural Mesothelioma: An Open-Label, Multicenter, Phase III Randomized Trial Journal of Clinical Oncology ·N. Bayman, W. Appel, Linda Ashcroft, David Baldwin, Andrew Bates, Liz Darlison, John Edwards, Veni Ezhil, David Gilligan, M. Hatton, A. Jegannathen, T. Mansy, Michael Peake, L. Pemberton, Robert C. Rintoul, M. Snee, W. David J. Ryder, Paul Taylor, Corinne Faivre‐Finn	2019	36
20	The relationship between smoking and quality of life in advanced lung cancer patients: a prospective longitudinal study Supportive Care in Cancer ·Sarah Danson, Christine Rowland, Richard Rowe, Sue Ellis, Carol Crabtree, Janet Horsman, Jonathan Wadsley, M. Hatton, Penella J. Woll, Christine Eiser	2015	34

About M. Hatton

M. Hatton is a scholar working on Radiation, Pulmonary and Respiratory Medicine, Oncology, Otorhinolaryngology and Hepatology, having authored 96 papers that have together received 3.3k indexed citations. Recurring topics across this work include Lung Cancer Diagnosis and Treatment (39 papers), Lung Cancer Research Studies (25 papers), Advanced Radiotherapy Techniques (23 papers), Lung Cancer Treatments and Mutations (23 papers), Atomic and Subatomic Physics Research (13 papers), Neuroendocrine Tumor Research Advances (12 papers), Brain Metastases and Treatment (11 papers) and Radiation Therapy and Dosimetry (8 papers). The work is most often cited by research in Oncology (2.0k citations), Pulmonary and Respiratory Medicine (2.2k citations), Radiation (473 citations), Epidemiology (1.0k citations) and Radiology, Nuclear Medicine and Imaging (562 citations). M. Hatton has collaborated with scholars based in United Kingdom, Netherlands and United States. Frequent co-authors include Corinne Faivre‐Finn, Suresh Senan, Ben J. Slotman, Elaine M. Rankin, M. Snee, Laurence Collette, G. Kramer, Pieter E. Postmus, E. Musat and Jim M. Wild. Their work appears in journals such as Clinical Oncology, Radiotherapy and Oncology, Lung Cancer, International Journal of Radiation Oncology*Biology*Physics and Journal of Thoracic Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact